Advance Universal Influenza Vaccine - FLU Mosaic Version 2 (flumosv2)

Contract Overview

Contract Amount: $141,656,003 ($141.7M)

Contractor: Leidos Biomedical Research Inc

Awarding Agency: Department of Health and Human Services

Start Date: 2021-02-16

End Date: 2031-01-28

Official Description: ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)